Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Solvay Partners with PrinterPrezz on 3D Printing for Medical Devices

Solvay and PrinterPrezz are collaborating to develop 3D printing selective laser sintering solutions for implants and other medical devices.   

Solvay and PrinterPrezz will co-develop 3D printing laser sintering solutions for implants and other medical devices. The partnership combines Solvay's materials expertise with PrinterPrezz's offering for qualification of medical devices to accelerate the adoption of 3D-printed implants and medical devices using Solvay’s latest AM powder technology for SLS.

Logo Solvay PrinterPrezzFurther, PrinterPrezz completed a $16 million Series A financing round to expand its engineering teams and ramp development efforts to improve medical device innovation. Solvay's venture capital fund, Solvay Ventures, participated in the round. Proceeds will support collaborative development efforts in specialized materials.

“Expanding healthcare solutions leveraging our high-performance polymers is a key part of Solvay’s growth strategy,” said Matt Jones, Managing Director of Solvay Ventures. “The cross functional team at PrinterPrezz has proven their ability to shorten the development cycle for 3D printed devices.”

D. One Vision Management through its DOV Singularity Fund served as the largest financial investor and co-lead, Boutique Venture Partners served as the investment syndicate organizer and co-lead, Berkeley Catalyst Fund served as co-lead investor and Solvay Ventures as strategic investor.

“By partnering together, Solvay and PrinterPrezz will accelerate the advancement of 3D printed medical devices, providing better patient outcomes through breakthrough technology as a part of our efforts to create sustainable shared value for all,” said Thomas Canova, head of Solvay Ventures.

In addition to the collaboration, “3D printing is evolving rapidly and is revolutionizing and the development of advanced health care applications from concept to manufacturing,” said Shri Shetty, CEO of PrinterPrezz. “The range of services offered by PrinterPrezz which includes engineering, clinical and regulatory guidance as well as access to 3D simulation software and state-of-the-art 3D printers provides Solvay a gateway for the development and optimization of their high-performance polymeric AM powders to advance the manufacturing of next generation implants and medical devices.”